Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Tarsus Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 220 | 3 | 246 | +29 |
| Shares | 44.9M | 81.8K | 44.1M | −761.0K (−1.7%) |
| Value | $2.67B | $4.86M | $3.61B | +$943.5M (+35.4%) |
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (23)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Macquarie Group Ltd | 833,437 | $49.5M |
| Polygon Management Ltd. | 125,000 | $7.43M |
| Affinity Asset Advisors, LLC | 125,000 | $7.43M |
| Tri Locum Partners LP | 119,260 | $7.09M |
| Capitolis Liquid Global Markets LLC | 102,600 | $6.10M |
| Dimensional Fund Advisors LP | 91,171 | $5.42M |
| Ally Bridge Group (NY) LLC | 70,778 | $4.21M |
| Standard Life Aberdeen plc | 51,678 | $3.07M |
| Citadel Advisors LLC | 43,281 | $2.57M |
| RFG Advisory, LLC | 14,941 | $887.9K |
| Capital Fund Management S.A. | 12,593 | $748.4K |
| Capstone Investment Advisors, LLC | 11,501 | $683.5K |
| Man Group plc | 11,211 | $666.3K |
| Omers Administration Corp | 10,200 | $606.2K |
| Ieq Capital, LLC | 7,627 | $453.3K |
| Inceptionr LLC | 7,218 | $429.0K |
| Nations Financial Group Inc, | 6,000 | $356.6K |
| Atom Investors LP | 5,494 | $326.5K |
| Dark Forest Capital Management LP | 5,062 | $300.8K |
| HSBC Holdings PLC | 3,521 | $209.6K |
| Group One Trading, L.P. | 1,163 | $69.1K |
| Crowley Wealth Management, Inc. | 450 | $26.7K |
| Catherine Avery Investment Management LLC | 10 | $594 |
Not filed for Q4 2025 yet (3)
Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 73,955 | $4.40M |
| CIBC Bancorp USA Inc. | 4,175 | $248.1K |
| Point72 (DIFC) Ltd | 3,663 | $217.7K |